Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236909 · ClinicalTrials.gov registry record · NA
Expanded Indications in the Adult Cochlear Implant Population
A NA study, sponsored by Med-El Corporation.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03236909 is a NA study that has completed, run by Med-El Corporation. The registered enrollment target is 44 participants.
The verdict
NCT03236909, a NA study, has completed, sponsored by Med-El Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this investigation is to expand FDA-approved labeling for MED-EL cochlear implants to include adults who have moderate to profound sensorineural hearing loss and obtain limited benefit from appropriately fit hearing aids.
Interventions
- DEVICE MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2023-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236909
The ClinicalTrials.gov registry entry for NCT03236909 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Med-El Corporation, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System is the first listed.
NCT03236909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03236909 about?
NCT03236909 is a clinical study titled "Expanded Indications in the Adult Cochlear Implant Population". The purpose of this investigation is to expand FDA-approved labeling for MED-EL cochlear implants to include adults who have moderate to profound sensorineural hearing loss and obtain limited benefit from appropriately fit hearing aids.
What is the current status of trial NCT03236909?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2018-04-16. Estimated completion is 2023-03-27.
What interventions are being tested in trial NCT03236909?
The interventions under investigation include: MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System (DEVICE).
Who is sponsoring clinical trial NCT03236909?
This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.